Skip to content

Efficacy of Kuberakshayoga tablet in primary dysmenorrhea

Randomised control trial on the efficacy of kuberakshayoga tablet in primary dysmenorrhea - NIL

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064575
Enrollment
214
Registered
2024-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

None listed

Sponsors

Kerala university of health sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: females with primary dysmenorrhea on basis of sign and symptoms with regular periods will be taken for study.

Exclusion criteria

Exclusion criteria: patients having any organic pathology of uterus and adnexae. patients with intrauterine contraceptive devices. patients with menorrhagia and metrorrhagia. patient planning for pregnancy. patients having menstrual period interval less than 21 days or more than 35 days

Design outcomes

Primary

MeasureTime frame
change in mean score value of pain in primary dysmenorrheaTimepoint: patient is advised to report in OP,during 4th day of menstruation, for 2 months and during follow up after 1 month

Secondary

MeasureTime frame
change in associated symptoms of primary dysmenorrhea Nausea,Vomiting,fatigue,headache,fainting Sweat,Diarrohea,constipation,Vaginal discharges,Breast tendernessTimepoint: 4th day day of menstruation for 2 months and during follow up after 1 month

Countries

India

Contacts

Public ContactDr NOBLETM

GOVT.AYURVEDA COLLEGE,TRIPUNITHURA

dransarypy@gmail.com9447568388

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026